Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.trimurthidrugs.com | |
Market Cap | 8.51 Cr. | |
Enterprise Value(EV) | 8.57 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -2.97 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 77.56 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 8.81 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 1.19 | Calculated using Price: 10.50 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.81 Cr. | 8,100,000 Shares |
FaceValue | 10 | |
Company Profile | ||
Trimurthi Drugs & Pharmaceuticals is an India-based company. The Company is engaged in the manufacturing, distribution, marketing and trading of pharmaceutical products. The Company's range of products include antibiotics, anti ulcer, anti inflammatory, antitussive/expectorant, cardiovascular, anti fungal, anti retroviral drugs, syrups and protein powder. The company since 1976 is built on the philosophy of commitment to quality and responsiveness. |
1 Day |
|
-4.81% |
1 Week |
|
-10.0% |
1 Month |
|
+0.10% |
3 Month |
|
-0.70% |
6 Month |
|
+23.75% |
1 Year |
|
+22.52% |
2 Year |
|
+117.58% |
5 Year |
|
+13.79% |
10 Year |
|
-46.77% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 3.86 | 1.24 | 1.13 | 0.29 | -3.07 | -1.34 | -2.41 | -42.83 | -29.63 | |
Return on Capital Employed (%) | 5.69 | 2.41 | 2.13 | 2.06 | -0.28 | 0.07 | -0.75 | -40.13 | -28.57 | |
Return on Assets (%) | 3.66 | 1.15 | 1.03 | 0.25 | -2.54 | -1.09 | -1.91 | -32.11 | -23.17 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 11 | 11 | 12 | 12 | 11 | 11 | 11 | 7 | 7 | 7 | |
Non Curr. Liab. | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | |
Curr. Liab. | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | |
Minority Int. | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | |
Equity & Liab. | 12 | 13 | 13 | 14 | 14 | 13 | 14 | 10 | 9 | 8 | |
Non Curr. Assets | 1 | 2 | 1 | 3 | 3 | 3 | 2 | 2 | 3 | 3 | |
Curr. Assets | 11 | 10 | 11 | 11 | 11 | 11 | 11 | 7 | 6 | 6 | |
Misc. Exp. not W/O | 0 | 0 | 0 | ||||||||
Total Assets | 12 | 13 | 13 | 14 | 14 | 13 | 14 | 10 | 9 | 8 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 6 | 6 | 6 | 9 | 11 | 10 | 10 | 9 | 9 | 4 | |
Other Income | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | ||
Total Income | 6 | 6 | 6 | 9 | 11 | 11 | 11 | 10 | 9 | 5 | |
Total Expenditure | -5 | -6 | -5 | -9 | -11 | -11 | -11 | -13 | -11 | -7 | |
PBIDT | 1 | 1 | 1 | 0 | 0 | 0 | 0 | -3 | -2 | -3 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | 0 | ||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -2 | -3 | |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Share Associate | 0 | 0 | 0 | ||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 | -2 | -2 | |
Adjusted EPS | 1 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | -2 | -3 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | -3 | 0 | 0 | 2 | -2 | 0 | -1 | 1 | 2 | 2 | |
Cash Fr. Inv. | 1 | 1 | -1 | -1 | 0 | -1 | 0 | 0 | 0 | -1 | |
Cash Fr. Finan. | 2 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | -1 | ||
Net Change | 0 | 1 | -1 | 1 | -1 | 0 | 0 | 1 | 1 | 1 | |
Cash & Cash Eqvt | 0 | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 2 | 3 |
Mon, 09 Jan 2023
Update On Shareholders Meeting update on shareholders meeting |
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 compliance under reg. 74(5) |
Thu, 29 Dec 2022
Closure of Trading Window Closure of trading window |
Wed, 25 Jan 2023 |
|
|
|
|
|